David Gómez-Almaguer
Universidad Autónoma de Nuevo León
401 Papers
1.3K Citations
David Gómez-Almaguer is an academic researcher from Universidad Autónoma de Nuevo León. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 30, co-authored 309 publications.
Chat about Author
Papers
Assessing the Efficacy of Mitoxantrone and Doxorubicin as Frontline Anthracyclines During Induction Therapy of Newly Diagnosed Acute Promyelocytic Leukemia.
José Carlos Jaime-Pérez,Eugenia M. Ramos-Dávila,Jesús D. Meléndez-Flores,Mariana González-Treviño,David Gómez-Almaguer +4 more
TL;DR: Using mitoxantrone or doxorubicin as induction therapy in newly diagnosed APL is a safe and adequate alternative with comparable outcomes to first-line agents in scenarios where the latter might not be readily available, such as in low-middle-income countries.
3
Outpatient reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia in children.
Laura Rodriguez-Romo,Consuelo Mancías-Guerra,Oscar González-Llano,José Carlos Jaime-Pérez,Sylvia Aide Martínez-Cabriales,Fernando García-Rodríguez,David Gómez-Almaguer +6 more
TL;DR: Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms and Advances in understanding the bleeding diathesis infactor V deficiency.
2
The Influence of Nutritional Status at Diagnosis of Childhood B-Cell Acute Lymphoblastic Leukemia on Survival Rates: Data from a Hispanic Cohort.
José Carlos Jaime-Pérez,Grecia A. Turrubiates-Hernández,Gerardo García-Salas,Anel M. de la Torre-Salinas,Patricia R. Ancer-Rodríguez,Laura Villarreal-Martínez,David Gómez-Almaguer +6 more
TL;DR: The impact of nutritional status at diagnosis of childhood acute lymphoblastic leukemia (ALL) on survival rates was assessed in a Hispanic cohort of children from 2011 to 2019, finding no association between nutritional status determined by CDC and WHO criteria and survival rates.
2
Flow cytometry data analysis of CD34+/CD133+ stem cells in bone marrow and peripheral blood and T, B, and NK cells after hematopoietic grafting.
José Carlos Jaime-Pérez,Cesar Daniel Villarreal-Villarreal,Eduardo Vázquez-Garza,Nereida Méndez-Ramírez,Rosario Salazar-Riojas,David Gómez-Almaguer +5 more
TL;DR: In this article, the authors provided flow cytometry information regarding levels of expression for hematopoietic stem cell markers CD34 and CD133 obtained simultaneously of the bone marrow and peripheral blood from recipients of allogeneic and autologous transplants of PB hematogenitors for treating hematological malignancies and who were clinically healthy after ≥100 days following the procedure.
2